"10.1371_journal.pone.0000683","plos one","2007-08-01T00:00:00Z","Marcella Funicello; Michela Novelli; Maurizio Ragni; Teresa Vottari; Cesare Cocuzza; Joaquin Soriano-Lopez; Chiara Chiellini; Federico Boschi; Pasquina Marzola; Pellegrino Masiello; Paul Saftig; Ferruccio Santini; Rene St-Jacques; Sylvie Desmarais; Nicolas Morin; Joseph Mancini; M David Percival; Aldo Pinchera; Margherita Maffei","Dulbecco Telethon Institute at Department of Endocrinology and Metabolism, University Hospital of Pisa, Pisa, Italy; Department of Experimental Pathology, Medical Biotechnologies, Infectivology and Epidemiology, University of Pisa, Pisa, Italy; Department of Morphological-Biomedical Sciences, Human Anatomy and Histology Section, Medical Faculty, University of Verona, Verona, Italy; Biochemical Institute, Christian-Albrechts University, Kiel, Germany; Department of Endocrinology and Metabolism, University Hospital of Pisa, Pisa, Italy; Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada; Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada","Conceived and designed the experiments: MM. Performed the experiments: MF MN MR TV CC JS CC FB RS SD NM JM. Analyzed the data: MF MN MR TV JS CC PM PM RS SD NM JM. Contributed reagents/materials/analysis tools: PS AP FS. Wrote the paper: MM PM FS MP.","Rene St-Jacques, Sylvie Desmarais, Nicolas Morin, Joseph Mancini and M. David Percival are employees of Merck and Co., Inc. which is investigating Cathepsin K inhibitors as potential therapeutics. All the other authors do not disclose any competing interest.","2007","08","Marcella Funicello","MF",19,TRUE,1,11,11,4,TRUE,TRUE,FALSE,0,NA,FALSE
